• Return to Headlines

Nektar Therapeut Set to Possibly Rebound After Yesterday's Selloff of 2.37%

By David Diaz

Nektar Therapeut (NASDAQ:NKTR) traded in a range yesterday that spanned from a low of $99.16 to a high of $103.96. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $100.61 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend recommended that subscribers consider buying shares of Nektar Therapeut on February 15th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $83.72. Since that recommendation, shares of Nektar Therapeut have risen 23.1%. We continue to monitor NKTR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Nektar Therapeut share prices have moved between a 52-week high of $111.36 and a 52-week low of $11.41 and are now trading 782% above that low price at $100.59 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 2.1%.

Keywords: rebounders nektar therapeut

Ticker(s): NKTR